Li, Ying
Liu, Hongwei
Shen, Chong
Li, Jianxin
Liu, Fangchao
Huang, Keyong
Gu, Dongfeng
Li, Yun
Lu, Xiangfeng
Funding for this research was provided by:
National Natural Science Foundation of China (82030102, 82330106)
the National High Level Hospital Clinical Research Funding (2022-GSP-GG-1, 2022-GSP- GG-2)
the Chinese Academy of Medical Sciences (CAMS) Innovation Fund for Medical Sciences (2021-I2M-1-010)
the Chinese Academy of Medical Sciences (CAMS) Innovation Fund for Medical Sciences (2019-I2M-2-003)
the Research Unit of Prospective Cohort of Cardiovascular Diseases and Cancers, CAMS (2019RU038)
Article History
Received: 13 October 2023
Accepted: 25 April 2024
First Online: 20 May 2024
Declarations
:
: The present study was conducted under UK Biobank application number 69815. The UK Biobank study was approved by the National Information Governance Board for Health and Social Care and North-West Multicentre Research Ethical Committee (11/NW/0382). All participants provided informed consent to participate.
: Not applicable.
: I have read the journal’s policy, and the authors declare that they have no competing interests.